IBMP
IBMP is dedicated to delivering biotechnological solutions to improve health and social well-being through innovative research, development, and production of diagnostic kits and biotechnological products. The institute emphasizes integrity, ethics, and governance in its operations, aiming to be a reference in health innovation and technology in Brazil.
Industries
Nr. of Employees
medium (51-250)
IBMP
Curitiba, Parana, Brazil, South America
Products
Molecular diagnostic kit portfolio (qPCR/RT-qPCR)
Range of nucleic acid detection kits using qPCR/RT-qPCR formatted for laboratory use; targets include arboviruses (Zika, dengue, chikungunya), febrile and neglected diseases (yellow fever, Chagas, malaria, rickettsiosis, trachoma), respiratory pathogens (Influenza A/B, SARS-CoV-2, RSV, adenovirus, rhinovirus/enterovirus), HPV high-risk genotypes and veterinary targets (rabies).
One-step RT-qPCR master mixes
Master mix reagent formulations for one-step RT-qPCR and PCR workflows provided as consumables for diagnostic testing and assay development.
Point-of-care antigen test (rapid immunoassay)
Portable antigen detection tests for rapid identification of respiratory pathogen antigens (example: SARS-CoV-2 antigen rapid test) intended for point-of-care or decentralized testing.
Molecular diagnostic kit portfolio (qPCR/RT-qPCR)
Range of nucleic acid detection kits using qPCR/RT-qPCR formatted for laboratory use; targets include arboviruses (Zika, dengue, chikungunya), febrile and neglected diseases (yellow fever, Chagas, malaria, rickettsiosis, trachoma), respiratory pathogens (Influenza A/B, SARS-CoV-2, RSV, adenovirus, rhinovirus/enterovirus), HPV high-risk genotypes and veterinary targets (rabies).
One-step RT-qPCR master mixes
Master mix reagent formulations for one-step RT-qPCR and PCR workflows provided as consumables for diagnostic testing and assay development.
Point-of-care antigen test (rapid immunoassay)
Portable antigen detection tests for rapid identification of respiratory pathogen antigens (example: SARS-CoV-2 antigen rapid test) intended for point-of-care or decentralized testing.
Services
High-throughput RT-PCR diagnostic testing
Clinical laboratory testing service performing large-scale RT-PCR diagnostics for public health needs and surveillance.
Contract manufacturing for diagnostic kits and reagents
Manufacturing and packaging of in vitro diagnostic kits, reagents and master mixes in a GMP/BPF-certified facility for third parties and internal brands.
Assay development and validation services
Custom development and analytical validation of molecular and antigen assays, including multiplexing, internal control integration and stability testing.
Genomic sequencing and precision public-health studies
NGS-based sequencing services and genomics research support for population studies, rare diseases and cancer research.
High-throughput RT-PCR diagnostic testing
Clinical laboratory testing service performing large-scale RT-PCR diagnostics for public health needs and surveillance.
Contract manufacturing for diagnostic kits and reagents
Manufacturing and packaging of in vitro diagnostic kits, reagents and master mixes in a GMP/BPF-certified facility for third parties and internal brands.
Assay development and validation services
Custom development and analytical validation of molecular and antigen assays, including multiplexing, internal control integration and stability testing.
Genomic sequencing and precision public-health studies
NGS-based sequencing services and genomics research support for population studies, rare diseases and cancer research.
Expertise Areas
- Molecular diagnostics development
- High-throughput RT-PCR testing and clinical diagnostics
- IVD manufacturing and GMP-compliant production
- Assay validation and analytical performance
Key Technologies
- Real-time PCR (qPCR/RT-qPCR)
- Multiplex PCR assays
- One-step RT-qPCR master mixes
- Next-generation sequencing (NGS)